# Daniel E. Spratt

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/daniel-e-spratt/

## Facts

| Field | Value |
| --- | --- |
| Citations | 26,098 |
| Field | Prostate Cancer Treatment and Research |
| h-index | 78 |
| i10-index | 330 |
| Last Known Institution | University Hospitals Seidman Cancer Center |
| OpenAlex ID | https://openalex.org/A5076238068 |
| ORCID iD | 0000-0002-5973-4741 |
| Works | 967 |

## Researcher papers

Showing 12 of 14.

- [Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/prostate-cancer-version-2-2019-nccn-clinical-practice-guidelines-in-oncology/)
- [Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer](https://scholariq.org/papers/genomic-hallmarks-and-structural-variation-in-metastatic-prostate-cancer/)
- [International Spine Radiosurgery Consortium Consensus Guidelines for Target Volume Definition in Spinal Stereotactic Radiosurgery](https://scholariq.org/papers/international-spine-radiosurgery-consortium-consensus-guidelines-for-target/)
- [Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/prostate-cancer-version-4-2023-nccn-clinical-practice-guidelines-in-oncology/)
- [Androgen Receptor Signaling Regulates DNA Repair in Prostate Cancers](https://scholariq.org/papers/androgen-receptor-signaling-regulates-dna-repair-in-prostate-cancers/)
- [NCCN Guidelines Insights: Prostate Cancer, Version 1.2021](https://scholariq.org/papers/nccn-guidelines-insights-prostate-cancer-version-1-2021/)
- [PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor–positive breast cancer](https://scholariq.org/papers/pi3k-inhibition-results-in-enhanced-estrogen-receptor-function-and-dependence-in/)
- [Association of Black Race With Prostate Cancer–Specific and Other-Cause Mortality](https://scholariq.org/papers/association-of-black-race-with-prostate-cancer-specific-and-other-cause/)
- [A New Risk Classification System for Therapeutic Decision Making with Intermediate-risk Prostate Cancer Patients Undergoing Dose-escalated External-beam Radiation Therapy](https://scholariq.org/papers/a-new-risk-classification-system-for-therapeutic-decision-making-with/)
- [Racial/Ethnic Disparities in Genomic Sequencing](https://scholariq.org/papers/racial-ethnic-disparities-in-genomic-sequencing/)
- [Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy](https://scholariq.org/papers/associations-of-luminal-and-basal-subtyping-of-prostate-cancer-with-prognosis/)
- [Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer](https://scholariq.org/papers/long-term-outcomes-of-stereotactic-body-radiotherapy-for-low-risk-and/)

## Researcher topics

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)
- [Advanced Radiotherapy Techniques](https://scholariq.org/topics/advanced-radiotherapy-techniques/)
- [Cancer, Lipids, and Metabolism](https://scholariq.org/topics/cancer-lipids-and-metabolism/)
- [Cancer, Hypoxia, and Metabolism](https://scholariq.org/topics/cancer-hypoxia-and-metabolism/)

## Researcher university

- [University Hospitals Seidman Cancer Center](https://scholariq.org/institutions/university-hospitals-seidman-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.